Form 4: Aspira Women's Health Director Acquires Shares and Warrants

Stefanie L. Cavanaugh, a director at Aspira Women's Health Inc., recently acquired 3,268 shares of common stock and warrants to purchase an additional 3,268 shares.

Summary

• On July 9, 2024, Stefanie L. Cavanaugh, a director of Aspira Women's Health Inc., acquired 3,268 shares of common stock.
• The transaction also included the acquisition of warrants to purchase 3,268 shares of common stock.
• Each share of common stock was purchased together with one warrant at a combined price of $1.53.
• The warrants have an exercise price of $2.25 and expire on July 9, 2027.
• Following the transaction, Ms. Cavanaugh directly owns 38,172 shares of Aspira Women's Health Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares and warrants suggests confidence, but the scale of the purchase is relatively small.

Positives

• A director's purchase of company stock and warrants can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in trading activities by company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's valuation and future performance.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Aspira Women's Health, Director, Insider Trading, Form 4, Stock, Warrants, Beneficial Ownership